Origen de la red de primer grado Brent Meadows.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Biotechnology | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Brent Meadows a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Wilfrid Laurier University | College/University | Undergraduate Degree | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Administrative Officer | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member | |
SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
Brandeis University | College/University | Graduate Degree | |
AVIVAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Mcmaster Innovation Park
Mcmaster Innovation Park Miscellaneous Commercial ServicesCommercial Services Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
IMV INC. | Biotechnology | Investor Relations Contact | |
Syracuse University | College/University | Masters Business Admin | |
Ernst & Young LLP (Canada)
Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
ATLANTIC COASTAL ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
University of Western Ontario | College/University | Doctorate Degree | |
Axcelon Biopolymers Corp.
Axcelon Biopolymers Corp. Electronic Equipment/InstrumentsElectronic Technology Axcelon Biopolymers Corp. provides medical devices for human health applications. It provides devices to those companies which uses nanotechnology to biodegradable polymer design and applications. Its technology includes stent coating, ophthalmology, drug delivery and regenerative medicine. The company is headquartered in Toronto, Canada | Electronic Equipment/Instruments | Chief Executive Officer | |
CardioGenics, Inc.
CardioGenics, Inc. BiotechnologyHealth Technology CardioGenics, Inc. manufactures biotechnology and medical devices. It develops in-vitro-diagnostics cardiac testing products. The company was founded in 1997 and is headquartered in Mississauga, Canada. | Biotechnology | Director/Board Member | |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
CARDIOGENICS HOLDINGS INC | Medical Specialties | Director/Board Member | |
CANADIAN OIL RECOVERY & REMEDIATION ENTERPRISES LTD. | Environmental Services | Director/Board Member | |
University of Toronto | College/University | Undergraduate Degree | |
Mentra Nova Enterprises, Inc. | President | ||
AVICANNA INC. | Biotechnology | Chairman | |
Panford Investment Corp. | Corporate Officer/Principal | ||
PACIFIC SOFTWARE, INC. | Packaged Software | Director/Board Member | |
A.C. SIMMONDS AND SONS INC | Movies/Entertainment | Director/Board Member | |
PANACEA GLOBAL INC | Medical Specialties | Chairman | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Pharmaceuticals: Major | Director/Board Member | |
PURE GLOBAL CANNABIS INC. | Pharmaceuticals: Other | Chairman | |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director of Finance/CFO |
Estadísticas
Internacional
Canadá | 24 |
Estados Unidos | 12 |
Islas Caimán | 2 |
Reino Unido | 2 |
China | 2 |
Sectorial
Health Technology | 19 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 3 |
Technology Services | 3 |
Operativa
Director/Board Member | 16 |
Corporate Officer/Principal | 8 |
Independent Dir/Board Member | 6 |
Director of Finance/CFO | 5 |
Chief Tech/Sci/R&D Officer | 5 |
Las relaciones más conectadas
Insiders | |
---|---|
Chandrakant Panchal | 22 |
Humphrey Gardner | 9 |
Elizabeth Williams | 6 |
Jeff Caravella | 3 |
Evelyn Pau | 2 |
Delphine Davan | 2 |
Eamonn Peters | 1 |
Minh To | 1 |
- Bolsa de valores
- Insiders
- Brent Meadows
- Conexiones Empresas